(HealthDay)—Women on antiepileptic drugs (AEDs) during pregnancy for epilepsy or other indications are at increased risk of giving birth to premature and small-for-gestational-age (SGA) infants, according to a study published ...
Sep 11, 2017
0
2
Concussion in teenagers increases the risk of multiple sclerosis (MS) in later life. However, there is no association with MS for concussion in younger children. This was reported by a new study, led by Scott Montgomery, ...
Sep 8, 2017
0
65
(HealthDay)—Chronic sleep restriction may lead to risk-seeking behavior, according to a study published online Aug. 21 in the Annals of Neurology.
Aug 25, 2017
1
10
(HealthDay)—For patients with super-refractory status epilepticus (SRSE), brexanolone as adjunctive therapy is tolerated and associated with a high rate of third-line agent (TLA) weaning, according to a study published ...
Aug 9, 2017
0
0
Johns Hopkins physicians report success in a small study of a modified skin biopsy that hastens the earlier diagnosis of an inherited and progressively fatal nerve disease and seems to offer a clearer view of the disorder's ...
Jul 11, 2017
0
4
Language disturbances (aphasia) are common after stroke and can manifest as difficulty identifying the correct word to use (semantic problems) and/or difficulty pronouncing words (phonemic problems). Speech therapy has long ...
Jul 10, 2017
0
392
(HealthDay)—A simple and rapid blood test can detect GLUT1 deficiency syndrome (DS), according to a study published online May 26 in the Annals of Neurology.
Jun 23, 2017
0
1
Working with colleagues from Harvard Medical School and Würzburg, researchers from Charité - Universitätsmedizin Berlin have been examining the use of deep brain stimulation in the treatment of Parkison's disease in an ...
Jun 23, 2017
0
6
Deep brain stimulation (DBS) of the ventral striatum/anterior limb of the internal capsule is safe and feasible in addressing the affective component of pain in patients with post-stroke pain syndrome.
Jun 20, 2017
0
3
New research from the University of Eastern Finland shows that the APP gene variant protecting against Alzheimer's disease significantly decreases plasma beta-amyloid levels in a population cohort. This is a very significant ...
Jun 20, 2017
0
1
